Metoclopramide in Parkinson’s — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Use a Parkinson’s-suitable antiemetic after prescriber review
This scenario assesses Metoclopramide in Parkinson’s in a UK pharmacy practice context. Metoclopramide is a dopamine antagonist and can worsen Parkinsonian symptoms. The best answer is Use a Parkinson’s-suitable antiemetic after prescriber review because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF